Physiogenex will be presenting a hyperinsulinemic euglycemic clamp study differentiating insulin analogues in STZ-rats, a model of experimental diabetes.
The study will be presented by Dr. François Briand, Director of Research and Business Development, during the ADA 2018 poster session, on Monday June the 25th, from noon to 1pm, poster #1773-P.

If you wish to make an appointment during the meeting with Dr. François Briand to discuss about your drug development project, please contact us.